GOT OCD - There's Help: Clinical Trial Is Recruiting People With Obsessive Compulsive Disorder

Understanding OCD
Obsessive-Compulsive Disorder is characterized by a relentless cycle of intrusive thoughts (obsessions) and compulsive behaviors. These obsessions, often distressing and intrusive, can range from fears of contamination, harm to loved ones, or even the fear of causing harm to oneself. In a desperate attempt to alleviate the anxiety triggered by these obsessions, individuals with OCD resort to compulsions, which are repetitive actions or mental rituals. These compulsions serve as temporary relief but eventually feed the cycle, reinforcing the disorder.

Many misconceptions surround OCD, and it is essential to dispel these myths to better understand the disorder. OCD is not a mere quirk or an idiosyncrasy but a Clinically Diagnosed Mental Health Condition. Contrary to popular belief, OCD is not just about cleanliness or a desire for orderliness; it can manifest in various forms, affecting every aspect of an individual's life.

Imagine being trapped in your own mind, unable to escape the relentless stream of distressing thoughts that hijack your consciousness. For those with OCD, this is an everyday reality. It's like walking on eggshells, where even the simplest of actions can set off a chain reaction of anxious thoughts and compulsive behaviors.

Meet Sarah, a 32-year-old Marketing Professional, who has been battling OCD since her early teens. Sarah's obsessions revolve around the fear of contamination, causing her to spend hours each day washing her hands. This behavior not only consumes her time but also prevents her from engaging in activities she once loved. Social events become a dreaded ordeal, and her professional life suffers due to constant handwashing interruptions.

The Weight Of Stigma
The Stigma surrounding Mental Health is often a significant barrier for those with OCD seeking help. Due to the misconception that OCD is a mere personality quirk or exaggerated behavior, individuals may hesitate to share their struggles or fear of being judged. This Stigma can lead to Isolation, worsening the already challenging experience of living with OCD.

It is essential to recognize that OCD is not a choice; it is a Medical Condition that requires understanding and empathy. Support from Friends, Family, and Mental Health Professionals can make a significant difference in the lives of those struggling with OCD.

While OCD is undoubtedly a source of Immense Pain and distress for those affected, it is crucial to acknowledge that individuals with OCD often demonstrate incredible resilience and strength. Many go on to lead fulfilling lives, pursuing successful careers, and maintaining meaningful relationships.

While living with OCD may seem like an insurmountable challenge, there is hope. Various treatment approaches, such as Cognitive-Behavioral Therapy (CBT) and Medication, have proven effective in Managing OCD Symptoms. There is even a Clinical Trial to Conduct New Research about the Disorder.

Clinical Trial
South Florida Research Phase I-IV, Inc. is actively recruiting people with Obsessive Compulsive Disorder (OCD) aged 18-65 for a New Clinical Research Study evaluating the Safety and Efficacy of an Investigational Treatment in adults. OCD is a Mental Health Disorder that affects one in 100 people and occurs when a person gets caught in a cycle of uncontrollable, reoccurring thoughts and behaviors. This Multicenter, Placebo Controlled, Phase 3 Clinical Trial is studying Adjunctive Troriluzole to treat the symptoms of OCD by targeting Glutamate. Glutamate is a Chemical found in the Brain that is believed to be a contributing factor to OCD.

“Alarmingly, it can take from 14 up to 17 years from the onset of symptoms for a person to get an appropriate Diagnosis and Effective Treatment for OCD,” said Silvia I. Silva-Duluc, Psychiatrist at South Florida ResearchPhase I-IV, Inc. and Investigator in the OCD Clinical Trial. “Unfortunately, one third of people with OCD do not respond to currently available Medications so new therapies are urgently needed. It’s been over two decades since the FDA-Approval of a new OCD Medication, which is why it is so important for people to participate in Clinical Trials. We are hopeful Troriluzole will help these individuals to better manage their Disorder and, in turn, have a better quality of life.”

Clinicians at South Florida Research Phase I-IV, Inc. are now seeking eligible participants for the Study. To Enroll, participants must be between age 18 and 65, believe they have symptoms of OCD or have been diagnosed with OCD, and not be taking Fluvoxamine (Luvox). For more information about participating in the Study at South Florida Research Phase I-IV, Inc., call: (305) 418-0841. Or visit: www.ocdtrials.com

Study Details
The Study will Enroll approximately 2,000 participants between the ages of 18 and 65 who will receive Adjunctive Troriluzole or Placebo for the treatment of OCD. The Efficacy of Adjunctive Troriluzole compared to Placebo will be measured by the Yale-Brown Obsessive Compulsive Scale, a scale designed to rate the severity and type of symptoms in those with the Disorder.